Acro Biomedical (ACBM) Net Cash Flow (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105.24% |
| Sep 30, 2025 | 2,009.78% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -129.03% |
| Jun 30, 2024 | 444.44% |
| Mar 31, 2024 | 92.23% |
| Dec 31, 2023 | -589.85% |
| Sep 30, 2023 | -74.94% |
| Jun 30, 2023 | 142.64% |
| Mar 31, 2023 | 46.50% |
| Dec 31, 2022 | -353.27% |
| Sep 30, 2022 | 101.18% |
| Jun 30, 2022 | -231.68% |
| Mar 31, 2022 | 541.67% |
| Dec 31, 2021 | 2.33% |
| Sep 30, 2021 | -131.83% |
| Jun 30, 2021 | 2,965.03% |
| Sep 30, 2020 | 97.81% |
| Jun 30, 2020 | -205.45% |
| Mar 31, 2020 | 1,833.51% |
| Dec 31, 2019 | 98.45% |
| Sep 30, 2019 | 3.32% |
| Jun 30, 2019 | -0.49% |
| Mar 31, 2019 | -202.02% |
| Dec 31, 2018 | 1,151.60% |
| Sep 30, 2018 | 99.26% |
| Jun 30, 2018 | -200.85% |
| Mar 31, 2018 | 1,738.92% |
| Dec 31, 2017 | -176.79% |
| Mar 31, 2017 | -20,655.63% |
| Dec 31, 2016 | 98.52% |
| Sep 30, 2016 | -71.54% |
| Jun 30, 2016 | 31.40% |
| Mar 31, 2016 | 28.18% |
| Dec 31, 2015 | -648.88% |